This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Angiogenesis Inhibitors
|
Academic Article
|
Thalidomide-associated deep vein thrombosis and pulmonary embolism.
|
Academic Article
|
Angiogenesis inhibitors.
|
Academic Article
|
Angiogenesis inhibitors in genitourinary cancers.
|
Academic Article
|
Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.
|
Academic Article
|
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.
|
Academic Article
|
Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
|
Academic Article
|
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
|
Academic Article
|
Targeted agents for the treatment of advanced renal cell carcinoma.
|
Academic Article
|
Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma.
|
Academic Article
|
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
|
Academic Article
|
Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study.
|
Academic Article
|
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC).
|
Academic Article
|
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
|
Academic Article
|
Effective therapy for metastatic renal cancer, whither to now.
|
Academic Article
|
Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.
|
Academic Article
|
Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.
|
Academic Article
|
Angiogenesis inhibition in non-clear cell renal cancer.
|
Academic Article
|
Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis.
|
Academic Article
|
Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.
|
Academic Article
|
Maturing of renal cancer therapeutics.
|
Academic Article
|
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.
|
Academic Article
|
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).
|
Academic Article
|
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer.
|
Academic Article
|
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial.
|